Edit |   |
---|---|
Antigenic Specificity | NCOA3 (N-term), 344-372 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human (predicted reactivity: rat) |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.5 |
Applications | Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This NCOA3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 344-372 amino acids from the N-terminal region of human NCOA3. The protein encoded by this gene is a nuclear receptorcoactivator that interacts with nuclear hormone receptors toenhance their transcriptional activator functions. The encodedprotein has histone acetyltransferase activity and recruitsp300/CBP-associated factor and CREB binding protein as part of amultisubunit coactivation complex. This protein is initially foundin the cytoplasm but is translocated into the nucleus uponphosphorylation. Several transcript variants encoding differentisoforms have been found for this gene. In addition, a polymorphi |
Immunogen | n/a |
Other Names | [Nuclear receptor coactivator 3; NCoA-3; ACTR; Amplified in breast cancer 1 protein; AIB-1; CBP-interacting protein; pCIP; Class E basic helix-loop-helix protein 42; bHLHe42; Receptor-associated coactivator 3; RAC-3; Steroid receptor coactivator protein 3; SRC-3; Thyroid hormone receptor activator molecule 1; TRAM-1; NCOA3; AIB1; BHLHE42; RAC3; TRAM1] |
Gene, Accession # | [NCOA3], Gene ID: 8202, NCBI: NP_001167559.1, UniProt: Q9Y6Q9 |
Catalog # | MBS9208054 |
Price | $165, $370 |
Order / More Info | NCOA3 (N-term), 344-372 Antibody from MYBIOSOURCE INC. |
Product Specific References | Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Cai, D., et al. Cancer Res. 70(16):6477-6485(2010) Kovanen, L., et al. Alcohol Alcohol. 45(4):303-311(2010) Karmakar, S., et al. Mol. Endocrinol. 24(6):1187-1202(2010) Kleibl, Z., et al. J. Cancer Res. Clin. Oncol. (2010) In press : |